206 related articles for article (PubMed ID: 22956587)
1. T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccination.
Schreiber TH; Wolf D; Bodero M; Gonzalez L; Podack ER
J Immunol; 2012 Oct; 189(7):3311-8. PubMed ID: 22956587
[TBL] [Abstract][Full Text] [Related]
2. 4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.
Dawicki W; Bertram EM; Sharpe AH; Watts TH
J Immunol; 2004 Nov; 173(10):5944-51. PubMed ID: 15528328
[TBL] [Abstract][Full Text] [Related]
3. Triggering of TNFRSF25 promotes CD8⁺ T-cell responses and anti-tumor immunity.
Slebioda TJ; Rowley TF; Ferdinand JR; Willoughby JE; Buchan SL; Taraban VY; Al-Shamkhani A
Eur J Immunol; 2011 Sep; 41(9):2606-11. PubMed ID: 21688261
[TBL] [Abstract][Full Text] [Related]
4. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
[TBL] [Abstract][Full Text] [Related]
5. Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo.
De Smedt T; Smith J; Baum P; Fanslow W; Butz E; Maliszewski C
J Immunol; 2002 Jan; 168(2):661-70. PubMed ID: 11777959
[TBL] [Abstract][Full Text] [Related]
6. CD63-Mediated Antigen Delivery into Extracellular Vesicles via DNA Vaccination Results in Robust CD8
Kanuma T; Yamamoto T; Kobiyama K; Moriishi E; Masuta Y; Kusakabe T; Ozasa K; Kuroda E; Jounai N; Ishii KJ
J Immunol; 2017 Jun; 198(12):4707-4715. PubMed ID: 28507029
[TBL] [Abstract][Full Text] [Related]
7. The adjuvant effects of Mycobacterium tuberculosis heat shock protein 70 result from the rapid and prolonged activation of antigen-specific CD8+ T cells in vivo.
Harmala LA; Ingulli EG; Curtsinger JM; Lucido MM; Schmidt CS; Weigel BJ; Blazar BR; Mescher MF; Pennell CA
J Immunol; 2002 Nov; 169(10):5622-9. PubMed ID: 12421941
[TBL] [Abstract][Full Text] [Related]
8. OX40 costimulation can abrogate Foxp3+ regulatory T cell-mediated suppression of antitumor immunity.
Kitamura N; Murata S; Ueki T; Mekata E; Reilly RT; Jaffee EM; Tani T
Int J Cancer; 2009 Aug; 125(3):630-8. PubMed ID: 19455675
[TBL] [Abstract][Full Text] [Related]
9. Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help.
Krishnan L; Sad S; Patel GB; Sprott GD
J Immunol; 2000 Nov; 165(9):5177-85. PubMed ID: 11046050
[TBL] [Abstract][Full Text] [Related]
10. Engagement of OX40 enhances antigen-specific CD4(+) T cell mobilization/memory development and humoral immunity: comparison of alphaOX-40 with alphaCTLA-4.
Evans DE; Prell RA; Thalhofer CJ; Hurwitz AA; Weinberg AD
J Immunol; 2001 Dec; 167(12):6804-11. PubMed ID: 11739496
[TBL] [Abstract][Full Text] [Related]
11. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses.
Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A
Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549
[TBL] [Abstract][Full Text] [Related]
12. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes.
Zaks K; Jordan M; Guth A; Sellins K; Kedl R; Izzo A; Bosio C; Dow S
J Immunol; 2006 Jun; 176(12):7335-45. PubMed ID: 16751377
[TBL] [Abstract][Full Text] [Related]
13. 4-1BB and OX40 stimulation enhance CD8 and CD4 T-cell responses to a DNA prime, poxvirus boost vaccine.
Munks MW; Mourich DV; Mittler RS; Weinberg AD; Hill AB
Immunology; 2004 Aug; 112(4):559-66. PubMed ID: 15270726
[TBL] [Abstract][Full Text] [Related]
14. 4-1BB ligand-mediated costimulation of human T cells induces CD4 and CD8 T cell expansion, cytokine production, and the development of cytolytic effector function.
Wen T; Bukczynski J; Watts TH
J Immunol; 2002 May; 168(10):4897-906. PubMed ID: 11994439
[TBL] [Abstract][Full Text] [Related]
15. Tumor-Unrelated CD4 T Cell Help Augments CD134 plus CD137 Dual Costimulation Tumor Therapy.
Mittal P; St Rose MC; Wang X; Ryan JM; Wasser JS; Vella AT; Adler AJ
J Immunol; 2015 Dec; 195(12):5816-26. PubMed ID: 26561553
[TBL] [Abstract][Full Text] [Related]
16. IL-4 directs both CD4 and CD8 T cells to produce Th2 cytokines in vitro, but only CD4 T cells produce these cytokines in response to alum-precipitated protein in vivo.
Serre K; Mohr E; Gaspal F; Lane PJ; Bird R; Cunningham AF; Maclennan IC
Mol Immunol; 2010 Jun; 47(10):1914-22. PubMed ID: 20392496
[TBL] [Abstract][Full Text] [Related]
17. ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells.
Duewell P; Kisser U; Heckelsmiller K; Hoves S; Stoitzner P; Koernig S; Morelli AB; Clausen BE; Dauer M; Eigler A; Anz D; Bourquin C; Maraskovsky E; Endres S; Schnurr M
J Immunol; 2011 Jul; 187(1):55-63. PubMed ID: 21613613
[TBL] [Abstract][Full Text] [Related]
18. In vivo investigation of twin-screw extruded lipid implants for vaccine delivery.
Even MP; Young K; Winter G; Hook S; Engert J
Eur J Pharm Biopharm; 2014 Jul; 87(2):338-46. PubMed ID: 24607791
[TBL] [Abstract][Full Text] [Related]
19. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses.
Ruby CE; Redmond WL; Haley D; Weinberg AD
Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611
[TBL] [Abstract][Full Text] [Related]
20. Enhanced CD4 T cell responsiveness in the absence of 4-1BB.
Lee SW; Vella AT; Kwon BS; Croft M
J Immunol; 2005 Jun; 174(11):6803-8. PubMed ID: 15905521
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]